Style & ShowbizHealth

Knee pain? Try Botox

HealthBy Sunday World
Knee pain? Try Botox

Suffering from knee pain? Botox may be the cure, as a new study has discovered the usually cosmetic treatment helped ease a painful joint condition which affects more than one in eight active individuals.

Scientists at Imperial College London and Fortius Clinic looked at 45 people suffering with what's known as lateral patellofemoral overload syndrome (LPOS), with sufferers experiencing severe pain at the side and front of their knee joint. It is often round in runners and cyclists.

Dysport - a protein known as a botulinum toxin, which is what Botox is - was injected into the muscle at the front and outside of the hip of the participants in the trial, then they were given personalised physiotherapy treatment.

In total 69 per cent didn't need any more procedures on the joint and after five years were free of pain entirely. This is a stark contrast to previous studies which showed that 80 per cent of people suffering from the condition still had ongoing symptoms after other treatments, while 74 per cent reported being less active.

Usual treatments include steroid injections, physiotherapy and anti-inflammatory drugs. If these fail, surgery is often considered as an option, and even then patients aren't always guaranteed the issue will go away completely.

"As a physiotherapist it can be incredibly frustrating to run out of treatment options for patients with this painful condition," study co-author Doctor Jo Stephen, of Imperial College London and Fortius, said. "Many athletes who took part in this study had exhausted all other treatment options and this was their last resort.

"We are really excited that our approach is showing positive results for patients, which could have implications for active people around the world."

Findings were published in the American Journal of Sports Medicine.

"Patients travelled from all over the country to take part in this study, which is an indication of their eagerness to find a solution to their discomfort," co-author David Urquhart, of Chelsea and Westminster Hospital, added.

Cover Media